Amici Capital’s Allergan plc AGN Stock Holding History

Amici Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-10,000	Closed	-$2.68M	–	135
2016 Q1	$2.68M	Buy	+10,000	New	+$2.86M	0.32%	59

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Amici Capital's AGN Position: Q2 2016 in Review

Amici Capital sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 10,000 shares — an estimated $2.68M sold.

Amici Capital first reported a position in AGN in Q1 2016 and held it in 1 quarter. The position peaked at $2.68M in Q1 2016. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

Amici Capital reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
Amici Capital sold 10,000 Allergan plc shares in Q2 2016, an estimated $2.68M.
Amici Capital first reported a position in Allergan plc in Q1 2016 and held it in 1 quarter.
Amici Capital's Allergan plc position peaked at $2.68M in Q1 2016.
1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Amici Capital's 13F filing for Q2 2016, filed 15 Aug 2016.